Navigation Links
CardioCareLive, First-Ever Online Cardiometabolic Conference, Debuts Today
Date:3/3/2009

Virtual Medical Event Available from the Convenience of a Computer www.CardioCareLive.com takes place entirely online Tuesday March 3 and Wednesday March 4 from 9:30 AM to 8:00 PM Eastern. Patch Adams, MD, the real physician behind the movie starring Robin Williams, is even slated to speak. To register now for free, visit cardioCareLive.com.

Needham, MA (PRWEB) March 3, 2009 -- CardioCareLive, the first-ever online-only conference for medical professionals who manage patients with cardiometabolic risk factors, begins today at 9:30 AM Eastern. Cardiologists, endocrinologists, primary care physicians and registered nurses can have their questions addressed live by leading experts in cardiometabolic care from the ease of a PC. This event offers live keynote presentations with Q & A, peer networking and an exhibit floor, entirely online at CardioCareLive.com on Tuesday March 3 and Wednesday March 4 from 9:30 AM to 8:00 PM Eastern.
CardioCareLive features leading cardiovascular experts live via video, such as Louis Aronne, MD; Christie Ballantyne, MD; Roger Blumenthal, MD; Robert Eckel, MD; Peter Libby, MD; Laurie Mosca, MD; Richard Nesto, MD; Clyde Yancy, MD and more. Patch Adams, MD, the real physician behind the movie starring Robin Williams, is even slated to speak.

Acknowledging the busy lives of physicians, CardioCareLive offers continuing education at no cost and completely online, and all pres
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Moet & Chandon Releases Grand Vintage 1929 Magnum Commemorating First-Ever Academy Awards(R) To Benefit Motion Picture & Television Fund
2. Nanyang Technological University launches first-ever sports degree in Singapore
3. San Diego Medical Community Receives First-Ever Accredited Palliative Medicine Fellowship Program
4. Foundation Kicks off First-Ever PLS Awareness Month
5. First-Ever Over-the-Counter Dual Action Iron Supplement Available at Major Retail Outlets in the United States; Bifera is a New, Innovative Dual Iron Supplement Now on the Market
6. Aethon Develops First-Ever Solution for Automated Replenishment of Pharmacy ADCs
7. Ronald McDonald House Charities Brings People Together Like Never Before with First-Ever, Multi-Channel Social Networking Campaign : Charity Finds New Ways to Encourage Seasonal Giving in Tough Economic Times
8. Two Men Complete First-Ever Walk Across the Country for Autism
9. Ford Motor Co. Tops First-Ever Healthcare Purchasing Power Survey
10. First-Ever Mapping of Cancer Patients Genome
11. Christopher & Dana Reeve Foundation Launches First-Ever National Advertising Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 2Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 4Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 5Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 6Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 7Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 8Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 9Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 10Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 11Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 2Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 3Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 4Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 2Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 3Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 4Health News:Zogenix Increases Series B Preferred Stock Financing to $71 Million, Raising $35 Million in Second Tranche 2Health News:New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director 2Health News:New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director 3
Breaking Medicine Technology:Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Exclusive Marketplace for Nursing Professionals Launched by Nurses Service Organization 47502 1Exclusive Marketplace for Nursing Professionals Launched by Nurses Service Organization 47502 2Exclusive Marketplace for Nursing Professionals Launched by Nurses Service Organization 47502 3Say Cheese With Milk 47498 1Say Cheese With Milk 47498 2Say Cheese With Milk 47498 3Say Cheese With Milk 47498 4Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators 28ACATA 29 47495 1Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators 28ACATA 29 47495 2Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators 28ACATA 29 47495 3